M Ozguroglu

Summary

Affiliation: Istanbul University
Country: Turkey

Publications

  1. ncbi Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma
    M Ozguroglu
    Cerrahpasa Medical School, Istanbul University, Department of Internal Medicine Yogurtçu Basi Sokagi, Akçira apt 20 3, Istanbul, 81030, Turkey
    Pathol Oncol Res 5:123-8. 1999
  2. ncbi Bilateral inflammatory breast metastases of epithelial ovarian cancer
    M Ozguroglu
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    Am J Clin Oncol 22:408-10. 1999
  3. ncbi Anorectal melanoma metastatic to the breast
    M Ozguroglu
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    J Clin Gastroenterol 29:197-9. 1999
  4. ncbi Serum erythropoietin level in anemic cancer patients
    M Ozguroglu
    Istanbul University, Cerrahpasa School of Medicine, Department of Internal Medicine, Section of Medical Oncology, Istanbul, Turkey
    Med Oncol 17:29-34. 2000
  5. ncbi Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma
    M Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Med Oncol 21:67-72. 2004
  6. ncbi Secretory carcinoma of the breast. Case report and review of the literature
    Mustafa Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Oncology 68:263-8. 2005
  7. ncbi Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer
    M Ozguroglu
    Section of Medical Oncology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Gynecol Cancer 16:394-6. 2006
  8. ncbi Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer
    D Tural
    1Department of Internal Medicine, Division of Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J BUON 18:385-90. 2013
  9. pmc Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
    D Tural
    Istanbul University Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, 34098 Istanbul, Turkey
    Br J Cancer 110:1968-76. 2014
  10. ncbi Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
    M Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Gynecol Cancer 18:809-12. 2008

Collaborators

Detail Information

Publications14

  1. ncbi Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma
    M Ozguroglu
    Cerrahpasa Medical School, Istanbul University, Department of Internal Medicine Yogurtçu Basi Sokagi, Akçira apt 20 3, Istanbul, 81030, Turkey
    Pathol Oncol Res 5:123-8. 1999
    ....
  2. ncbi Bilateral inflammatory breast metastases of epithelial ovarian cancer
    M Ozguroglu
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    Am J Clin Oncol 22:408-10. 1999
    ..She died within 3 months of breast involvement. Our case has unique features, with both bilateral breast metastases and also with its inflammatory pattern of metastasis, which is extremely rare...
  3. ncbi Anorectal melanoma metastatic to the breast
    M Ozguroglu
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    J Clin Gastroenterol 29:197-9. 1999
    ..We present a case of inoperable anorectal melanoma which metastasized to the left breast and abdominal lymph nodes. We also briefly reviewed the appropriate literature, emphasizing the diagnostic and therapeutic approaches...
  4. ncbi Serum erythropoietin level in anemic cancer patients
    M Ozguroglu
    Istanbul University, Cerrahpasa School of Medicine, Department of Internal Medicine, Section of Medical Oncology, Istanbul, Turkey
    Med Oncol 17:29-34. 2000
    ..In this study, we demonstrated that anemia in cancer patients was caused by blunted erythropoietin response, rather than its quantitative deficiency. Serial measurements, however, should be considered in patients receiving chemotherapy...
  5. ncbi Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma
    M Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Med Oncol 21:67-72. 2004
    ..In seropositive patients, HBV DNA should be determined and antiviral prophylaxis with lamivudine should be initiated before any treatment...
  6. ncbi Secretory carcinoma of the breast. Case report and review of the literature
    Mustafa Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Oncology 68:263-8. 2005
    ..She is disease free with a follow-up period of 24 months. Preoperative chemotherapy should be primarily replaced by curative surgery in such indolent cancers, despite locally advanced disease...
  7. ncbi Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer
    M Ozguroglu
    Section of Medical Oncology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Gynecol Cancer 16:394-6. 2006
    ..This uncommon adverse effect of carboplatin and paclitaxel combination was discussed, and all the literature in English related with the toxicity of paclitaxel and carboplatin were reviewed...
  8. ncbi Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer
    D Tural
    1Department of Internal Medicine, Division of Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J BUON 18:385-90. 2013
    ..The primary aim of this study was to compare the rates of local and distant recurrence and overall survival (OS) in LARC patients who received pre-CRT vs postoperative (post) CRT...
  9. pmc Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
    D Tural
    Istanbul University Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, 34098 Istanbul, Turkey
    Br J Cancer 110:1968-76. 2014
    ....
  10. ncbi Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
    M Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Gynecol Cancer 18:809-12. 2008
    ..One of the best predictors to response is the histologic pattern. Predominating histopathologic feature (carcinoma or sarcoma) should be taken into consideration in predicting the response and planning the chemotherapy regimen...
  11. ncbi Should mammographic screening be done in primary ovarian cancer?: A case control study in Turkish women
    M Ozguroglu
    Department of Internal Medicine, Section of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Med Oncol 21:139-43. 2004
    ..5%), mammographic imaging detected metastatic disease to the breast from the ovaries. Mammography should therefore be considered in patients with ovarian cancer independent of age...
  12. ncbi The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer
    F Selcukbiricik
    University of Istanbul, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J BUON 18:116-23. 2013
    ..The purpose of this study was to investigate the predictive value of the presence of K-RAS and B-RAF mutations on the outcome of patients with mCRC treated with FOLFIRI and bevacizumab combination therapy...
  13. ncbi Metastasis from breast carcinoma to endometrial polyp
    O Aydin
    Department of Pathology, Cerrahpasa School of Medicine, Istanbul University, Turkey
    Eur J Gynaecol Oncol 29:666-8. 2008
    ..She underwent hysteroscopy with biopsy. Microscopic examination revealed an endometrial polyp which contained foci of adenocarcinoma. The morphologic features of the tumor were identical to the original breast carcinoma...
  14. ncbi Role of the antiangiogenetic drug paclitaxel on healing of intestinal anastomosis: an experimental study
    S Yuceyar
    Department of Surgery, Cerrahpasa Medical Faculty, Istanbul University, Turkey
    Tech Coloproctol 9:201-5. 2005
    ..The aim of this experimental study was to evaluate, taking into consideration its antiangiogenetic properties, the effects of intraperitoneal paclitaxel on healing of end to end colonic anastomosis...